WallStSmart

National Research Corp (NRC)vsR1 RCM Inc (RCM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

R1 RCM Inc generates 1693% more annual revenue ($2.46B vs $137.39M). NRC leads profitability with a 8.4% profit margin vs -2.5%. NRC earns a higher WallStSmart Score of 42/100 (D).

NRC

Hold

42

out of 100

Grade: D

Growth: 2.0Profit: 8.5Value: 5.7Quality: 5.0

RCM

Hold

39

out of 100

Grade: F

Growth: 6.0Profit: 3.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NRCSignificantly Overvalued (-304.4%)

Margin of Safety

-304.4%

Fair Value

$3.40

Current Price

$17.18

$13.78 premium

UndervaluedFair: $3.40Overvalued

Intrinsic value data unavailable for RCM.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NRC2 strengths · Avg: 10.0/10
Return on EquityProfitability
51.2%10/10

Every $100 of equity generates 51 in profit

Operating MarginProfitability
32.2%10/10

Strong operational efficiency at 32.2%

RCM1 strengths · Avg: 8.0/10
Price/BookValuation
2.1x8/10

Reasonable price relative to book value

Areas to Watch

NRC4 concerns · Avg: 2.8/10
P/E RatioValuation
35.0x4/10

Premium valuation, high expectations priced in

Market CapQuality
$398.29M3/10

Smaller company, higher risk/reward

Price/BookValuation
27.7x2/10

Trading at 27.7x book value

Revenue GrowthGrowth
-4.6%2/10

Revenue declined 4.6%

RCM4 concerns · Avg: 2.8/10
PEG RatioValuation
2.064/10

Expensive relative to growth rate

Operating MarginProfitability
3.8%3/10

Operating margin of 3.8%

Return on EquityProfitability
-2.2%2/10

ROE of -2.2% — below average capital efficiency

EPS GrowthGrowth
-99.3%2/10

Earnings declined 99.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : NRC

The strongest argument for NRC centers on Return on Equity, Operating Margin.

Bull Case : RCM

The strongest argument for RCM centers on Price/Book. Revenue growth of 14.7% demonstrates continued momentum.

Bear Case : NRC

The primary concerns for NRC are P/E Ratio, Market Cap, Price/Book.

Bear Case : RCM

The primary concerns for RCM are PEG Ratio, Operating Margin, Return on Equity.

Key Dynamics to Monitor

NRC profiles as a value stock while RCM is a turnaround play — different risk/reward profiles.

RCM carries more volatility with a beta of 0.84 — expect wider price swings.

RCM is growing revenue faster at 14.7% — sustainability is the question.

RCM generates stronger free cash flow (60M), providing more financial flexibility.

Bottom Line

NRC scores higher overall (42/100 vs 39/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

National Research Corp

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

National Research Corporation provides analytics and information that make it easy to measure and improve the patient and employee experience in the United States and Canada. The company is headquartered in Lincoln, Nebraska.

R1 RCM Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

R1 RCM Inc (RCM) is a leading provider of technology-enabled revenue cycle management services, specializing in optimizing the financial performance of healthcare organizations. By leveraging advanced analytics and industry expertise, R1 RCM delivers comprehensive solutions that streamline patient billing processes and enhance operational efficiencies across a diverse portfolio of clients, including hospitals and outpatient facilities. The company's innovative approach not only improves revenue capture but also elevates the patient experience, positioning R1 RCM as a key player in the evolving healthcare landscape. With a robust growth strategy focused on expanding its service offerings and market reach, R1 RCM is poised to capitalize on the increasing demand for effective revenue cycle solutions in the healthcare sector.

Want to dig deeper into these stocks?